Harrow, Inc. Operating Leases, Future Minimum Payments, Due in Rolling after Year Five
Harrow, Inc. (HROW) had Operating Leases, Future Minimum Payments, Due in Rolling after Year Five of $196.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive · last filed 2019-03-12
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Rolling after Year Five $196.00K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Rolling after Year Five $79.00K.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Rolling after Year Five $213.00K.
- 2014-12-31: Operating Leases, Future Minimum Payments, Due in Rolling after Year Five $478.47K.
| Period end | Operating Leases, Future Minimum Payments, Due in Rolling after Year Five |
|---|---|
| 2018-12-31 | $196.00K 10-K · filed 2019-03-12 |
| 2016-12-31 | $79.00K 10-K · filed 2017-03-21 |
| 2015-12-31 | $213.00K 10-K · filed 2016-03-23 |
| 2014-12-31 | $478.47K 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |